BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19169914)

  • 61. Irreversible cerebellar toxicity after infusional 5-flurouracil therapy.
    Suresh P; Kapoor R; Kapur BN
    Indian J Cancer; 2015; 52(4):627-8. PubMed ID: 26960499
    [No Abstract]   [Full Text] [Related]  

  • 62. Sub-staging colorectal cancers and adjuvant treatments.
    Lorenzon L; Balducci G; Ferri M
    J Am Coll Surg; 2015 Mar; 220(3):379-81. PubMed ID: 25700909
    [No Abstract]   [Full Text] [Related]  

  • 63. Combination therapy with oxaliplatin and 5-fluorouracil in a patient with severe hepatic dysfunction associated with metastatic adenocarcinoma of the large bowel.
    Grenader T; Goldberg A; Gabizon A
    Anticancer Drugs; 2009 Oct; 20(9):845-7. PubMed ID: 19633535
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Cancer, reactive oxygen species and chemotherapy-induced peripheral neuropathy].
    Batteux F; Cerles O; Nicco C
    Med Sci (Paris); 2014 Dec; 30(12):1078-80. PubMed ID: 25537035
    [No Abstract]   [Full Text] [Related]  

  • 65. Oxaliplatin, 5-fluorouracil, and leucovorin as second-line treatment for advanced pancreatic cancer.
    Novarino A; Satolli MA; Chiappino I; Giacobino A; Bellone G; Rahimi F; Milanesi E; Bertetto O; Ciuffreda L
    Am J Clin Oncol; 2009 Feb; 32(1):44-8. PubMed ID: 19194124
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [A case of stage IV AFP producing cecal cancer responding to mFOLFOX6 leading to a partial response].
    Seshimo K; Yamashita Y; Oishi M; Yokomichi N; Ikeda H; Katoh H; Yamamura M; Kodera M; Maejima R; Kobayashi K; Takita K
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1375-7. PubMed ID: 19692783
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].
    Tamura K
    Rinsho Ketsueki; 2009 Apr; 50(4):276-81. PubMed ID: 19404020
    [No Abstract]   [Full Text] [Related]  

  • 68. Does palliative chemotherapy palliate?
    Markman M
    J Support Oncol; 2003; 1(1):65-7. PubMed ID: 15352646
    [No Abstract]   [Full Text] [Related]  

  • 69. [A case of severe electrolytic disorder after adjuvant chemotherapy for esophageal cancer].
    Fukuhara K; Omura T; Katsuragi K; Osugi H; Lee S; Kishida S
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1359-61. PubMed ID: 19692779
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A phase II study of modified FOLFOX as first-line chemotherapy in elderly patients with advanced gastric cancer.
    Zhao JG; Qiu F; Xiong JP; Zhang L; Xiang XJ; Yu F; Yan J; Zhan ZY; Feng M
    Anticancer Drugs; 2009 Apr; 20(4):281-6. PubMed ID: 19247179
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Resection of hepatic metastasis after 5-fluorouracil and cofactor for colon cancer.
    Costantini CL; Reid TR; Bouvet M
    Hepatogastroenterology; 2009; 56(91-92):645-9. PubMed ID: 19621672
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Indications and results of palliative gastric resection in advanced gastric carcinoma].
    Dittmar Y; Voigt R; Heise M; Rabsch A; Jandt K; Settmacher U
    Zentralbl Chir; 2009 Feb; 134(1):77-82. PubMed ID: 19242887
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma.
    Lim JY; Cho JY; Oh KJ; Choi SH; Lee SI; Jeung HC
    Chemotherapy; 2009; 55(4):200-6. PubMed ID: 19451710
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma.
    Chen JS; Chao Y; Yang TS; Chou WC; Chen LT; Lee KD; Lin YC
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):151-7. PubMed ID: 19455334
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Second-look operation for colon carcinoma after fluorouracil therapy.
    Mackman S; Curreri AR; Ansfield FJ
    Arch Surg; 1970 Apr; 100(4):527-31. PubMed ID: 4190476
    [No Abstract]   [Full Text] [Related]  

  • 76. The combination of 5-fluorouracil, leukovorin, etoposide, and cisplatin (FLEP) in patients with metastatic esophageal cancer. A single-institution experience.
    Jonak C; Raderer M; Zacherl J; Prager G; Troch M; Ba-Ssalamah A; Hejna M
    Anticancer Res; 2008; 28(6B):4101-4. PubMed ID: 19192667
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Therapy of porphyrias].
    Burg G
    Dtsch Med Wochenschr; 1971 May; 96(21):914-5. PubMed ID: 4996324
    [No Abstract]   [Full Text] [Related]  

  • 78. Colon cancer 15 years after ureterosigmoidostomy.
    Chan CC; Tan A; Salman H
    J Clin Oncol; 2008 Apr; 26(10):1755-7. PubMed ID: 18375906
    [No Abstract]   [Full Text] [Related]  

  • 79. [MR and biliary tract].
    Chabanova E; Møller JM; Løgager V; Thomsen HS
    Ugeskr Laeger; 2005 Aug; 167(35):3321-2; author reply 3322-3. PubMed ID: 16138986
    [No Abstract]   [Full Text] [Related]  

  • 80. Hiccups during Chemotherapy: What Should We Do?
    Kang JH; Bruera E
    J Palliat Med; 2015 Jul; 18(7):572. PubMed ID: 26091417
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.